AR109951A1 - INDAZOL COMPOUNDS WITH ANTITUMOR PROPERTIES - Google Patents
INDAZOL COMPOUNDS WITH ANTITUMOR PROPERTIESInfo
- Publication number
- AR109951A1 AR109951A1 ARP170102869A ARP170102869A AR109951A1 AR 109951 A1 AR109951 A1 AR 109951A1 AR P170102869 A ARP170102869 A AR P170102869A AR P170102869 A ARP170102869 A AR P170102869A AR 109951 A1 AR109951 A1 AR 109951A1
- Authority
- AR
- Argentina
- Prior art keywords
- ch2f
- chf2
- compounds
- ome
- pharmaceutically acceptable
- Prior art date
Links
Abstract
Se relaciona con compuestos y con las sales de los mismos aceptables desde el punto de vista farmacéutico, con los procesos y productos intermedios que se utilizan para su preparación, con las composiciones farmacéuticas que los contienen así como con su uso en el tratamiento de los trastornos proliferativos de las células. Reivindicación 1: Un compuesto de la fórmula (1), caracterizado porque: A es CR² o N; G es CR³ o N; D es CR⁴ o N; E es CR⁵ o N; Q es O, NH o NMe; R¹ es CH₂F, CHF₂ o CF₃; R² es H, F, Cl, Me, CN, OMe o OEt; R³ es H o F; R⁴ es H, F, CN u OMe; R⁵ es H o F; R⁶ es H, Me, CH₂F, CHF₂ o CF₃; R⁷ es H o Me; R⁸ es alquilo C₁₋₃, CH₂F, CHF₂, CF₃ o cicloalquilo C₃₋₄; R⁹ es Me, F o CH₂F; R¹⁰ es Me, F, CH₂F, CHF₂, CF₃, CH₂OMe o CH₂OH; R¹¹ es H o F; o R¹⁰ y R¹¹ tomados junto con el átomo de carbono al cual ellos están enlazados forman un anillo de ciclopropilo o un anillo de oxetano; R¹² es independientemente seleccionado de F o Me; R¹³ es H o F; y a es 0, 1 ó 2; o una sal del mismo aceptable desde el punto de vista farmacéutico.It relates to compounds and the pharmaceutically acceptable salts thereof, with the processes and intermediates that are used for their preparation, with the pharmaceutical compositions that contain them as well as with their use in the treatment of disorders. proliferative cells. Claim 1: A compound of the formula (1), characterized in that: A is CR² or N; G is CR³ or N; D is CR⁴ or N; E is CR⁵ or N; Q is O, NH or NMe; R¹ is CH₂F, CHF₂ or CF₃; R² is H, F, Cl, Me, CN, OMe or OEt; R³ is H or F; R⁴ is H, F, CN or OMe; R⁵ is H or F; R⁶ is H, Me, CH₂F, CHF₂ or CF₃; R⁷ is H or Me; R⁸ is C₁₋₃ alkyl, CH₂F, CHF₂, CF₃ or C₃₋₄ cycloalkyl; R⁹ is Me, F or CH₂F; R¹⁰ is Me, F, CH₂F, CHF₂, CF₃, CH₂OMe or CH₂OH; R¹¹ is H or F; or R¹⁰ and R¹¹ taken together with the carbon atom to which they are attached form a cyclopropyl ring or an oxetane ring; R¹² is independently selected from F or Me; R¹³ is H or F; and a is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662411799P | 2016-10-24 | 2016-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109951A1 true AR109951A1 (en) | 2019-02-06 |
Family
ID=65728648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102869A AR109951A1 (en) | 2016-10-24 | 2017-10-13 | INDAZOL COMPOUNDS WITH ANTITUMOR PROPERTIES |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR109951A1 (en) |
| HR (1) | HRP20191812T1 (en) |
| RS (1) | RS62937B1 (en) |
-
2017
- 2017-10-13 RS RS20220170A patent/RS62937B1/en unknown
- 2017-10-13 AR ARP170102869A patent/AR109951A1/en unknown
-
2019
- 2019-10-04 HR HRP20191812TT patent/HRP20191812T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20191812T1 (en) | 2019-12-27 |
| RS62937B1 (en) | 2022-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP19028657A (en) | DERIVATIVES OF 6,7,8,9-TETRAHIDRO-3H-PIRAZOLO [4,3-F] ISOQUINOLINE USEFUL IN THE TREATMENT OF CANCER | |
| NI201700020A (en) | AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS | |
| AR103252A1 (en) | QUINAZOLINE COMPOUNDS | |
| AR089143A1 (en) | SUBSTITUTED TRIAZOLOPIRIDINS WITH INHIBITING ACTIVITY OF TTK | |
| CO2018011408A2 (en) | Pyrimidine compounds as inhibitors of jak kinase | |
| AR101189A1 (en) | ANTIPROLIFERATIVE NITROGEN HETEROCICLES AND THEIR METHODS OF USE | |
| CL2013002690A1 (en) | Compounds derived from bis (fluoroalkyl) -1,4-benzodiazepinone, notch inhibitors; crystalline compound; pharmaceutical composition that includes them; pharmaceutical combination; and its use for the treatment of cancer. | |
| AR104025A1 (en) | PIPERAZINE CARBAMATES AS MODULATORS OF MAGL AND / OR ABHD6, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
| AR099228A1 (en) | FXIA MACROCYCLIC INHIBITORS THAT HAVE HETEROCYCLIC GROUPS | |
| AR107054A1 (en) | DERIVATIVES OF ISOINDOL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM FOR THE TREATMENT OF DISEASES MEDIATED BY RORg AND RORgt | |
| AR094735A1 (en) | BENZAMIDS REPLACED WITH ACTIVITY TO RECEPTORS EP4 | |
| AR105875A1 (en) | DERIVATIVES OF 2-OXO-1,2-DIHYDROPIRIDINE AS BROMODOMINIUM INHIBITORS | |
| AR122096A2 (en) | CREATINE PRODRURM COMPOUNDS AND COMPOSITIONS COMPRISING THEM | |
| CR20160527A (en) | CARBOXAMIDE DERIVATIVES | |
| UY36123A (en) | CARBOXAMIDE DERIVATIVES | |
| AR099867A1 (en) | FUSED IMIDAZOBENZOTIAZOLO COMPOUNDS | |
| CY1120744T1 (en) | AZAINDOLIS ACETIC ACID PRODUCERS AND THE USE OF THESE AS REGULATORY PROSTAGLANDIN RECEPTORS D2 | |
| AR111271A1 (en) | DOUBLE INHIBITORS OF MAGL AND FAAH | |
| CL2019003467A1 (en) | 5,6-fused bicyclic compounds and compositions for the treatment of parasitic diseases. | |
| AR103156A1 (en) | PIRIDIL-CICLOALQUIL-CARBOXYLIC ACIDS SUBSTITUTED, COMPOSITIONS THAT CONTAIN THEM AND USES OF THE SAME | |
| AR099690A1 (en) | P-REPLACED ASYMMETRIC UREAS AS MODULATORS OF GHRELINA ACTIVITY | |
| AR109951A1 (en) | INDAZOL COMPOUNDS WITH ANTITUMOR PROPERTIES | |
| PE20211454A1 (en) | IMIDAZOPYRIDINE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT | |
| UY36084A (en) | POLICYCLIC HERG ACTIVATORS | |
| AR120158A2 (en) | SUBSTITUTED INDOL MONO OR DI DERIVATIVES AS INHIBITORS OF DENGUE VIRAL REPLICATION |